Search Results - Verena Schöning

Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients by Verena Schöning, Felix Hammann

Connect to this object online.

Editorial: Spotlight on artificial intelligence in experimental pharmacology and drug discovery by Verena Schöning, Amit Khurana, Aleksandra Karolak

Connect to this object online.

A Comparison of Nine Machine Learning Mutagenicity Models and Their Application for Predicting Pyrrolizidine Alkaloids by Christoph Helma, Verena Schöning, Jürgen Drewe, Jürgen Drewe, Philipp Boss

Connect to this object online.

Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in <i>Cimicifuga racemosa</i> as Critical Mediators of AMPK Activation by Jürgen Drewe, Verena Schöning, Ombeline Danton, Alexander Schenk, Georg Boonen

Connect to this object online.

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing by Charlotte Kern, Charlotte Kern, Verena Schöning, Carlos Chaccour, Carlos Chaccour, Carlos Chaccour, Felix Hammann

Connect to this object online.

Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study by Verena Schöning, Charlotte Kern, Charlotte Kern, Carlos Chaccour, Carlos Chaccour, Carlos Chaccour, Felix Hammann

Connect to this object online.

Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive <i>Staphylococcus aureus</i> Infections: A Prospective Cohort Study by Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, Adrian Egli, Stephan Moser, Vladimira Hinic, Richard Kuehl, Stefano Bassetti, Martin Siegemund, Katharina M. Rentsch, Laura Hermann, Verena Schöning, Felix Hammann, Parham Sendi, Michael Osthoff

Connect to this object online.